Last reviewed · How we verify

NCT04689763

The Effectiveness of Lifestyle Redesign Training in Elderly With Cognitive Decline

Status unknown NA Last updated 17 May 2021
What this trial tests

NA trial testing Training in Aging in 50 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
1 January 2023
1 January 2023

Quick facts

Lead sponsorChang Gung Memorial Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment50
Start date1 October 2021
Primary completion1 January 2023
Estimated completion1 January 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 55 to 90, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Taiwan is already an aging society due to the rapid increase of the aging population. To cope with this situation, it is necessary to make preparations for the care of the elderly. World Health Organization (WHO) proposed aging health strategy in recent years, and the community participation is the most important for the elderly. The courses provided by the community empowering are important to promote the healthy life of the elderly. However, at this stage, there are relatively few courses related to cognitive functions, life-style activities and aging education. It is needed to add more courses related to multi-domain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Training

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04689763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing